Eurofins-Cerep SA (PA:ALECR) — Market Cap & Net Worth

$79.70 Million USD  · €68.17 Million EUR  · Rank #20060

Market Cap & Net Worth: Eurofins-Cerep SA (ALECR)

Eurofins-Cerep SA (PA:ALECR) has a market capitalization of $79.70 Million (€68.17 Million) as of May 2, 2026. Listed on the PA stock exchange, this France-based company holds position #20060 globally and #312 in its home market, demonstrating a 0.63% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eurofins-Cerep SA's stock price €15900.00 by its total outstanding shares 5044 (5.04K). Analyse Eurofins-Cerep SA operating cash flow efficiency to see how efficiently the company converts income to cash.

Eurofins-Cerep SA Market Cap History: 2025 to 2026

Eurofins-Cerep SA's market capitalization history from 2025 to 2026. Data shows growth from $104.97 Million to $93.76 Million (0.00% CAGR).

Eurofins-Cerep SA Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Eurofins-Cerep SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of ALECR by Market Capitalization

Companies near Eurofins-Cerep SA in the global market cap rankings as of May 2, 2026.

Key companies related to Eurofins-Cerep SA by market ranking:

  • Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
  • Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
  • IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
  • LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#126 Thermo Fisher Scientific Inc NYSE:TMO $176.29 Billion $469.21
#189 Danaher Corporation NYSE:DHR $123.72 Billion $175.15
#578 IDEXX Laboratories Inc NASDAQ:IDXX $45.31 Billion $567.46
#643 LONZA GROUP UNSP.ADR 1/10 F:LO3A $41.04 Billion €54.50

Eurofins-Cerep SA Historical Marketcap From 2025 to 2026

Between 2025 and today, Eurofins-Cerep SA's market cap moved from $104.97 Million to $ 93.76 Million, with a yearly change of 0.00%.

Year Market Cap Change (%)
2026 €93.76 Million -10.67%
2025 €104.97 Million --

End of Day Market Cap According to Different Sources

On May 2nd, 2026 the market cap of Eurofins-Cerep SA was reported to be:

Source Market Cap
Yahoo Finance $79.70 Million USD
MoneyControl $79.70 Million USD
MarketWatch $79.70 Million USD
marketcap.company $79.70 Million USD
Reuters $79.70 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Eurofins-Cerep SA

PA:ALECR France Diagnostics & Research
Market Cap
$93.76 Million
€80.20 Million EUR
Market Cap Rank
#20060 Global
#312 in France
Share Price
€15900.00
Change (1 day)
+0.63%
52-Week Range
€15400.00 - €18600.00
All Time High
€18600.00
About

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company's research services include compound management, and high-throughput screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and… Read more